Factors associated with primary rifampicin-resistant/multidrug-resistant TB: a case-control study
The International Journal of Tuberculosis and Lung Disease · 2026
DOI: 10.5588/ijtld.26.0038 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2026. Verfasst von T Zangpo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gidakom Hospital, National Medical Services, Ministry of Health, Thimphu, Bhutan. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Rifampin, Antitubercular Agents, Tuberculosis, Pulmonary.
Abstract (Originalsprache)
BACKGROUND
Multidrug-resistant TB (MDR-TB) threatens TB control in Bhutan. According to the 2017 national Drug Resistance Surveillance report of the Royal Centre for Disease Control, 13.7% of new pulmonary TB cases had rifampicin resistance, of whom 98% were also resistant to isoniazid. We investigated the factors associated with primary rifampicin-resistant/multidrug-resistant TB (RR/MDR-TB) among new pulmonary TB patients.
METHODS
We conducted a nationwide case-control study including 46 laboratory-confirmed primary RR/MDR-TB cases and 138 drug-susceptible pulmonary TB controls (1:3 ratio). Multivariable logistic regression identified factors independently associated with primary RR/MDR-TB.
RESULTS
Factors associated with primary RR/MDR-TB were delay in diagnosis (adjusted odds ratio [AOR] 24.9, P < 0.001), poor household ventilation (AOR 3.6, P = 0.023), contact with MDR-TB patients (AOR 7.2, P < 0.001), living alone (AOR 10.8, P = 0.016), perceived health staff unfriendliness (AOR 9.6, P = 0.004), and TB medicine unavailability (AOR 16.5, P = 0.024). Increasing age was associated with lower odds of RR/MDR-TB (AOR 0.94 per year, P = 0.005).
CONCLUSION
Primary RR/MDR-TB in Bhutan was strongly associated with delayed diagnosis, contact with known MDR-TB patients and modifiable health-system factors. Expanding rapid molecular testing, strengthening contact investigation, and improving patient-centred care are critical to interrupt transmission and sustain TB control gains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gidakom Hospital, National Medical Services, Ministry of Health, Thimphu, Bhutan.
- Medical Education Centre for Research, Innovation and Training, Khesar Gyalpo University of Medical Sciences of Bhutan, Thimphu, Bhutan.
- National TB Control Program, Department of Public Health, Ministry of Health, Thimphu, Bhutan.
- Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
- Jigme Dorji Wangchuk National Referral Hospital, Thimphu, Bhutan.
- Khesar Gyalpo University of Health Sciences of Bhutan, Thimphu, Bhutan.
Zitieren
APA
Zangpo, T., Norbu, T., Tenzin, P., Nima, G., Dorji, C., Dhakal, G. P., Dorjee, S., & Tsheten, T. (2026). Factors associated with primary rifampicin-resistant/multidrug-resistant TB: a case-control study. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.26.0038
Vancouver
Zangpo T, Norbu T, Tenzin P, Nima G, Dorji C, Dhakal GP, et al. Factors associated with primary rifampicin-resistant/multidrug-resistant TB: a case-control study. The International Journal of Tuberculosis and Lung Disease. 2026. doi:10.5588/ijtld.26.0038
BibTeX
@article{Zangpo2026,
author = {Zangpo, T and Norbu, T and Tenzin, P and Nima, G and Dorji, C and Dhakal, G P and Dorjee, S and Tsheten, T},
title = {Factors associated with primary rifampicin-resistant/multidrug-resistant TB: a case-control study},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2026},
doi = {10.5588/ijtld.26.0038}
}
EUVIMED